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Increasing evidence reveals that extracellular matrix components can be regarded as a group
of mediators in intrathymic T-cell migration and/or differentiation. Yet, little is kown about
the expression and putative function of one particular extracellular matrix protein, namely,
tenascin in the thymus. Herein we investigated, by means of immunocytochemistry,
tenascin expression in normal infant and fetal human thymuses, as well as in cultures of
thymic microenvironmental cells.
In situ, tenascin distribution is restricted to the medulla and cortico-medullary regions of
normal thymuses. This pattern thus differed from that of fibronectin, laminin and type IV
collagen, in which subseptal basement membranes were strongly labeled. Interestingly,
tenascin did not co-localize with the cytokeratin-defined thymic epithelial cell network. This
was in keeping with the in vitro data showing that tenascin-bearing cells were nonepithelial
(and probably nonfibroblastic) microenvironmental elements.
Studies with fetal thymuses revealed a developmentally regulated expression of tenascin,
with a faint but consistent network labeling, in thymic rudiments as early as 12 weeks of
gestational age, that progressed to a strong TN expression at 18 weeks of fetal development,
which was similar to the distribution pattern observed thereafter, including postnatally.
Our results clearly indicated that tenascin is constitutively expressed in the human
thymus, since early stages of thymic ontogeny, and suggest that the cell type responsible for
its secretion is a nonepithelial microenvironmental cell.
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INTRODUCTION
Tenascin (TN) is an extracellular matrix glycoprotein
involved in mesenchymal-epithelial cell interactions
during morphogenetic events including embryonic
development (Aufderheide and Ekblom, 1988;
Inaguma et al., 1988; Thesleff et al., 1990), tissue
repair (Donaldson et al., 1991), inflammation
(Mackie et al., 1988), and cancer (Mackie et al.,
1987; Inaguma et al., 1988; Soini et al., 1992a). Its
expression is temporally regulated in embryonic
tissues, although in some adult tissues it remains
constitutive (Crossin et al., 1986; Natali et al., 1991;
Saga et al., 1991).
Biochemically, TN is a complex structure com-
posed of six covalently linked polypeptides and
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containing several EGF-life (epidermal growth fac-
tor) and fibronectin type III repeats (Jones et al.,
1989; Saga et al., 1991). Additionally, isoforms of
tenascin have been described, although specific
roles for each isoform remain to be determined
(Aufderheide and Ekblom, 1988; Chiquet-
Ehrismann, 1990; Prieto et al., 1990).
Tenascin modulates cellular adhesion to other
extracellular matrix proteins such as fibronectin
(Chiquet-Ehrismann et al., 1988; Lotz et al., 1989).
It was shown to provide opposite signals, leading
either to adhesive or antiadhesive effects, which can
be exerted by different sites of TN molecule (Spring
et al., 1989).
The immunomodulatory activities ascribed to TN
include its ability in regulating transient adhesion of
monocytes as well as B and T lymphocytes. In this
context, TN was shown to alter T-cell behaviour
(Ruegg et al., 1989).
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It is noteworthy that TN seems to be constitu-
tively expressed in human and murine lymphoid
tissues as spleen and lymph nodes (Liakka and
Autio-Harmainen, 1992; Soini et al., 1992b; Ocklind
et al., 1993). Particularly regarding the thymus,
Natali et al., (1991) did not detect tenascin either in
fetal or adult organs, as assessed by immunocyto-
chemistry. However, intrathymic expression of this
molecule was suggested, because a 5.5-6 kb TN
transcript and the respective protein band have
been evidenced in murine developing and adult
organs (Saga et al., 1991; Ocklind et al., 1993).
The cell type(s) involved in the putative TN
expression within the organ is still a matter of
debate. Yet, this is a relevant issue if one consider
that intrathymic events of T-cell differentiation are
driven by the so-called thymic microenvironment, a
tridimensional network composed of distinct cell
types, the major one corresponding to thymic epi-
thelial cells (TEC) (see reviews Boyd and Hugo,
1991; van Ewijk, 1991; Boyd et al., 1993).
Lastly, a body of evidence came to implicate
extracellular matrix (ECM) components as further
mediators of this intrathymic T-cell migration and/
or differentiation process (Savino et al., 1993).
Taken together, the data discussed before led us
to study TN expression in the human thymus, and
to search for which cell type would be responsible
for producing this extracellular matrix component in
the organ.
MATERIAL AND METHODS
Thymus Fragments
Fetal thymuses were obtained from Miguel Couto
Hospital (Rio de Janeiro), from apparently normal
fetuses, whose development was compatible with
the ascribed gestational age, which varied from 12
to 30 weeks. Fragments from normal infant thy-
muses were obtained from 6 children undergoing
surgery for correcting congenital cardiac malforma-
tions. Specimens were either immediately frozen for
further criostat sectioning or put into sterile Hank’s
solution for settling primary cultures of microenvir-
onmental cells.
Antibodies
An anti-TN rabbit serum was kindly provided by
Dr. Ruth Chiquet-Ehrismann (Friedrich Miescher
Institut, Basel, Switzerland). This reagent was pro-
duced after immunizing rabbits with purified
chicken TN, and can recognize TN from different
species (Chiquet and Fambrough, 1984a, 1984b).
Additionally, it was shown not to cross-react with
fibronectin (Chiquet and Fambrough, 1984a). A
further anti-TN rabbit serum was purchased from
Gibco-BRL (Gaithersburg, MD). The anti-TN mono-
oclonal antibody (mAb), clone EB2 was purchased
from Biohit (Helsinki, Finland) and was originally
described elsewhere (Howeedy et al., 1990).
In addition to anti-TN reagents, antibodies recog-
nizing distinct ECM components were obtained
from Institute Pasteur (Centre de Radioanalyse,
Lyon). All were polyclonal immunesera produced in
rabbits by injection of human plasma fibronectin
(FN), type IV collagen (TIV-C), or laminin (LN)
purified from the murine EHS (Engelbreth Holm-
Swarm) sarcoma (Grimaud et al., 1980). These
reagents recognize their corresponding molecules in
normal human thymuses (Savino and Berrih, 1984;
Berrih et al., 1985). Lastly, a polyclonal anti-
cytokeratin (CK) rabbit serum (immunoglobulin
fraction of rabbit antiserum to human cytokeratins
(Dako Corp., Sta. Barbara, CA) and anti-CK MAbs
(clones KL1 and KL4 from Immunotech, Marseille)
were used in double-labeling immunofluorescence
experiments. These reagents were proved to entirely
decorate the human thymic epithelium in situ and in
vitro (Berrih et al., 1984, 1985). The Ig fraction of
rabbit antiserum to human factor VIII related anti-
gen (Dako Corp.,) was used to stain the vascular
endothelium. Second fluorescent antibodies in-
cluded fluorescein- or rhodamine-labeled goat anti-
rabbit Ig sera (respectively GAR/FITC or GAR/
TRITC), a goat anti-mouse Ig (GAM/FITC), and a
donkey anti-goat Ig (DAG-FITC). These reagents
were purchased from Biosys (Compiegne, France).
Primary Cultures of Human Thymic Stromal
Cells
Human thymus fragments from 5 normal individu-
als were minced into tiny fragments that were led to
adhere onto 25-ml culture flasks during 1 hour.
Primary cultures were then settled as previously
described (Papiernik et al., 1975; Berrih et al., 1985)
using RPMI-1640 medium supplemented with 10%
heat-inactivated fetal calf serum, 2x 10-3M L-
glutamine, 10- 3M sodium pyruvate, 5 x 10-SM 2-
mercaptoethanol, 100 IU/ml penicillin, and 100
tg/ml streptomycin (Sigma Chemical Co., St.TENASCIN EXPRESSION IN HUMAN THYMUS 141
Louis). Cultures were kept at 37C in a humidified
atmosphere containing 5% CO2. Monolayers of
thymic microenvironmental cells thus obtained
were washed in PBS, fixed with methanol for 10
min, and stored at 20C until being processed for
immunocytochemistry.
Immunocytochemistry
Five%tm thick thymus frozen sections or human
thymic stromal cultures, respectively fixed in cold
acetone or absolute methanol for 10 min, were
processed for immunocytochemistry as detailed be-
fore (Berrih et al., 1995). Briefly, specimens were
incubated with adequate dilutions of a given anti-
TN primary antibody, washed in PBS, and subse-
quently incubated with the appropriate secondary
antibody. In the case of 12-week fetal thymus
sections, a third antibody (DAG-FITC) was neces-
sary in order to amplify the positive signal obtained
after incubation with the anti-TN polyclonal Ab
plus the secondary Ab (GAR-FITC).
In order to determine whether TN distribution
pattern in situ and in vitro co-localized with thymic
epithelial cells, specimens were subjected to double-
labeling immunofluorescence. In some experiments,
the anti-TN serum was revealed with the GAR/
TRITC whereas the anti-CK MAb was evidenced
with the GAM/FITC. Further specimens were
double-labeled using the anti-TN MAb and the
anti-CK rabbit serum, respectively, revealed with
the GAM/FITC and GAR/TRITC reagents.
Topographic relationships between TN distribu-
tion and blood vessels were evaluated by double-
labeling using the anti-TN serum and the anti-factor
VIII related antigen Ab (herein used as an endothe-
lium marker) that had the GAM/FITC and GAR/
TRITC as respective revealing systems.
Lastly, the pattern of tenascin distribution was
compared to that of other ECM proteins. For that,
the anti-TN mAb was double-labeled with each of
the anti-ECM serum, as mentioned before.
applied. Tenascin immunoreactivity was restricted
to the medulla and cortico-medullary junction of the
thymic lobules.
This contrasted with the negative pattern ob-
served at the border and within connective tissue
septae, as well as in typical cortical areas (Fig. 1).
This distribution pattern thus differed from that
described for basement membrane proteins such as
fibronectin, laminin, and type IV collagen, in which
subseptal basement membranes were strongly la-
beled (Berrih et al., 1985). In fact, we confirmed
such difference by performing double-labeling im-
munofluorescenc in which TN was detected simul-
taneously with other ECM proteins, including
fibronectin, laminin, and type IV collagen (Fig. 2).
Because TN-labeling adjacently to blo)d vessels
was apparent, we also performed dual immuno-
fluororescenc for simultaneous detection of TN and
vascular endothelia. We noticed that TN labeling
was rather restricted to adventitial layers of blood
vessels, whereas endothelial cells, evidenced with
the anti-factor VIII mAb, remained negative (not
shown).
The further relevant question concerning in-
trathymic tenascin expression referred to the cell
type responsible for its production in normal condi-
tions. In this respect, double-labeling immunofluo-
rescence using anti-TN and anti-CK reagents
revealed that in situ, TN distribution did not co-
localize with the CK-defined thymic epithelial cell
RESULTS
In Situ Distribution of Tenascin in Normal
Human Thymuses
The presence of tenascin in normal infant thymus
sections was consistently detected and exhibited the
same pattern, independently of the anti-TN reagent
FIGURE 1. Restricted in situ distribution of tenascin in normal
human thymus as immunohistochemically revealed with the
anti-tenascin monoclonal antibody. Dashed line represents the
cortico-medullary limits, whereas a perilobular septum is indi-
cated with the arrow. M: medulla; C: cortex. Magnification:
x 150.142 C.S. FREITAS et al.
FIGURE 2. Partial co-llcalization of tenascin and other basement membrane proteins in the normal infant thymus. In panels (a) and
(b), sections were double-labeled with anti-tenascin mAb and anti-type IV collagen serum, respectively. Note the septal basement
membrane is type IV collagen-positive but TN-negative. In contrast, in the medullary region, the two proteins are virtually
co-localized. Panels (c) and (d) depict a medullary area double-labeled for detection of tenascin (c) and laminin (d). The blood vessel
shown in the center of the field (arrow) revealed that, although the basement membrane is double-positive for TN and LN, an external
(adventitial) layer is only labeled for TN. Dashed lines represent the cortico-medullary limits. S: septum; HC: Hassall’s corpuscle.
Magnification: x 250.
network, although in the medulla, TN labeling could
be detected adjacently to epithelial cells (Fig. 3).
cellular fibers containing both laminin and TN could
be observed.
Expression of Tenascin by Cultured Thymic
Microenvironmental Cells
We also investigated TN expression in vitro, using
primary cultures developed from explants of normal
infant thymuses. In this system, we found that CK
(used as TEC marker) and TN labelings were mu-
tually exclusive (Fig. 4). Moreover, the relatively few
TN-bearing cells did not exhibit the typical fibro-
blast spindle-shaped profile. Yet, double-labeling
experiments showed that TN-containing cells could
also express laminin (Fig. 4). In this respect, extra-
Expression of Tenascin in Thymus Ontogeny
Fetal thymus specimens with 12, 18, 25, and 30
weeks of gestational age were analyzed for tenascin
expression and distribution, in relationship to the
epithelial network. At 12 weeks, intrathymic tena-
scin expression was apparently incipient, because a
positive immunocytochemical signal only could be
clearly detected by the use of a three-layer labeling.
Moreover, the TN distribution pattern at this gesta-
tional age was peculiar, ocurring in both peripheral
and central regions of the thymic lobules. From theTENASCIN EXPRESSION IN HUMAN THYMUS 143
FIGURE 3. Tenascin does not co-localize with epithelial (CK-positive) cells in normal infant thymus. Sections were double-labeled
with anti-tenascin polyclonal serum [panels (a) and (c)] and the anti-cytokeratin mAb KL1 [(b) and (d)]. Note that in the cortex, TN
is absent in the epithelial network, and within the medulla, the TN-bearing network is rather adjacent to the epithelial cells. Dashed
lines represent the cortico-medullary junction. S: septum; C: cortex; M: medulla. Magnification: x 250
18th week forward, the TN network was strongly
labeled (even using a two-layer labeling), and the
medullary-restricted topography already could be
evidenced, similarly to what was observed in infant
thymuses (Fig. 5).
A further aspect, which can be observed in Fig. 6,
was that even in fetal stages during thymus onto-
geny, TN staining was seen adjacently to the epi-
thelial network, but never superposed to it.
DISCUSSION
The present work represents an immunocytochem-
ical survey regarding the localization of tenascin in
the human thymus.
One relevant tissue concerning our study is that
TN expression already could be detected in 12-week
thymus rudiments, remaining constitutively in nor-
mal infant, as well as adult MG-associated hyper-
plastic organs (not shown). Nevertheless, because in
early stages of thymus ontogeny TN labeling was
incipient, it is possible that the expression of this
molecule in the human thymus is developmentally
upregulated. Such possibility is further supported
by the differential topography of TN labeling in
12-week fetal thymus, comprising peripheral and
central areas of thymic lobules.
In any case, our findings are in keeping with
recent data revealing mRNA transcripts for TN in
developing and adult murine thymuses (Saga et al.,
1991; Ocklind et al., 1993), and places the thymus
as one of the few organs in which TN expression is
not down-regulated after fetal life. Interestingly, this
seems to be a general feature in the immune system,
because TN was also detected in spleen and lymph
nodes (Liakka and Autio-Harmainen 1992; Ocklind
et al., 1993). Taking into account that TN is appar-
ently involved in regulating transient lymphocyte
adhesion events (Ruegg et al., 1989), it is possible144 C.S. FREITAS et al.
FIGURE 4. Expression of tenascin by cultured human thymic microenvironmental cells. Cell layers were double-labeled for detection
of tenascin [panels (a), (c), and (e)] and cytokeratin [panels (b) and (d) or laminin [panel (f)]. Note the mutual exclusive labeling for
TN and CK. Differently, TN-bearing cells also produce laminin. A TN/LN double-positive extracellular fiber can actually be seen
(arrow). Magnification: x 250.
that TN plays a physiological role in lymphocyte
migration, in both central and peripheral lymphoid
organs. Should it be the case, one could predict that
a similar cell would be responsible for TN synthesis
in the various lymphoid organs. Yet, Ocklind et al.
(1993) recently suggested that in mice, epithelial
cells (which are restricted to the thymus, not exist-
ing in peripheral lymphoid organs) would be re-
sponsible for TN expression. However, our data
concerning double-labeling immunofluorescence
performed in situ and in vitro virtually discarded the
hypothesis raised by those authors. One mightTENASCIN EXPRESSION IN HUMAN THYMUS 145
FIGURE 5. Tenascin expression during human thymus onto-
geny. By 12. weeks of gestational age [panel (a)] the TN network
(evidenced herein with a three-layer immunofluorescence) com-
prised both peripheral and central areas of the thymic lobules.
The medullary-restricted topography, becomes apparent in 18-
weeks-old thymus [panel (b)]. Such a pattern is maintained
thereafter, as exemplified at 25 weeks [panel (c)]. As in the adult
pattern, cortical regions and septa (arrows) are negative for
tenascin expression during thymus ontogeny. Magnification:
x 150.
argue that in those studies, the species analyzed was
not the same. Nonetheless, we obtained similar
results in mice (unpublisHed observations), which is
in keeping with the phylogenetic conservation of
extracellular matrix components in respect to their
intrathymic distribution (Berrih et al., 1985; Lannes-
Vieira et al., 1991; Meireles de Souza et al., 1993).
Additionally, typical fibroblasts do not seem to
secrete tenascin in the thymus. This is supported by
the virtual absence of TN within the thymic septa
(which contain fibroblasts), and by the negative
staining observed in spindle-shaped cells that grow
in primary culture of human thymic microenviron-
mental cells, and that can even form in vitro sep-
tumlike multicellular structures (not shown).
A reticular cell of mesenchymal origin thus could
be incriminated as the source of tenascin, both
intrathymically and in the peripheral lymphoid or-
gans. In fact, the perivascular and reticular TN
distribution within the thymus and in both lymph
node and spleen would fit with this possibility.
Moreoever, in vitro, these TN-bearing cells also
produce laminin, and the two ECM proteins can be
found in the same extracellular fiber. Thus, a peri-
cyte might be the source of tenascin within the
immune system. Further work will hopefully test
this possibility.
Lastly, it remains to be determined the role of
tenascin in the physiology of the thymus and
peripheral lymphoid organs. By taking into ac-
count its topography, adjacently to blood vessels
and migrating cells, it is feasible to conceive that
tenascin may be implicated in the exit of the
lymphocytes from these organs, a hypothesis that
is presently under investigation.
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FIGURE 6. Tenascin does not co-localize with epithelial (CK-positive cells) in fetal thymuses. Panels (a, c) and (b, d) depict
respectively, anti-cytokeatin (mAb KL4) and anti-TN in 12-week-old thymus. In panels (c) and (d), a medullary region is seen in a
18-week-old thymus with TN staining being seen adjacent to epithelial cells, apparently surrounding vessels. Magnifications: x 150
and x 250, respectively, for panels (a, b) and (c, d).
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